PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study

Chen, MF; Wang, ZH; Liu, ZM; Deng, T; Wang, XD; Chang, ZW; Zhang, Q; Yang, WL; Liu, N; Ji, Z; Zhang, XT; Wang, XC; Peng, Z; Li, Y; Cao, YJ; Jin, X; Lu, HX; Qu, HJ; Tang, Y; Xu, CL; Fang, WJ; Zhang, HY; Yan, D; Wang, L; Li, JY; Zhang, JD; Wang, QW; Xue, LY; Yin, F; Han, GJ; Cheng, ZQ; Liu, Q; Jin, YD; Zhang, YJ; Li, LX; Cao, BS; Yao, YH; Chen, ZY; Zou, JL; Ying, JE; Wei, Q; Tian, TT; Zhao, WF; Li, LM; Zhang, T; Song, FH; Ba, Y; Li, N; Gao, H; Ji, YH; Bao, LY; Zhao, XC; Cai, JP; Yuan, ZP; Shen, L; Li, J

Li, J (通讯作者),Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China.

JCO PRECISION ONCOLOGY, 2023; 7 ():

Abstract

PURPOSETo investigate the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy versus anti-PD-1/PD-L1 monotherapy in advanced microsatellite instabilit......

Full Text Link